Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

United Therapeutics (UTHR) Other Gross PP&E Adjustments (2016 - 2025)

United Therapeutics (UTHR) has disclosed Other Gross PP&E Adjustments for 16 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 34.07% to $2.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Dec 2025, up 34.07% year-over-year, with the annual reading at $2.3 billion for FY2025, 34.07% up from the prior year.
  • Other Gross PP&E Adjustments hit $2.3 billion in Q4 2025 for United Therapeutics, up from $2.1 billion in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.3 billion in Q4 2025 to a low of $1.0 billion in Q1 2021.
  • Historically, Other Gross PP&E Adjustments has averaged $1.5 billion across 5 years, with a median of $1.4 billion in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: grew 7.92% in 2021 and later soared 34.07% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $1.1 billion in 2021, then grew by 10.76% to $1.2 billion in 2022, then rose by 18.44% to $1.5 billion in 2023, then grew by 16.29% to $1.7 billion in 2024, then surged by 34.07% to $2.3 billion in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for UTHR at $2.3 billion in Q4 2025, $2.1 billion in Q3 2025, and $1.9 billion in Q2 2025.